Zymeworks
$25.629876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$25.62
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.42 (-1.61%) Today
$0.00 (0.00%) As of 4:02 PM EDT after-hours
Why Robinhood?
You can buy or sell Zymeworks and other stocks, options, ETFs, and crypto commission-free!
About ZYME
Zymeworks Inc., also called Zymeworks, is a clinical-stage biopharmaceutical company, which engages in the discovery, development and commercialization of biotherapeutics. Its product, ZW25 and ZW49 are a bispecific antibody that cans two non-overlapping epitopes. Read More The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani, and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.
CEO
Employees
183
Headquarters
Vancouver, British Columbia
Founded
2003
Market Cap
822.99M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
404.37K
High Today
$26.07
Low Today
$25.44
Open Price
$26.05
Volume
306.19K
52 Week High
$29.75
52 Week Low
$10.72
Collections
Price Paid on Robinhood
69% Higher
Right Now
52 Week Low
$10.72
Average Price Paid
$15.15
52 Week High
$29.00
Analyst Ratings
90%
of 10 ratings
Buy
90%
Hold
10%
Sell
0%
ZYME Earnings
-$0.83
-$0.13
$0.58
$1.28
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
—
Actual
Expected Nov 5, After Hours